Cargando…
Editorial: Advance in B-cell therapies for the treatment of rheumatic and musculoskeletal diseases
Autores principales: | Md Yusof, Md Yuzaiful, Alivernini, Stefano, Chatzidionysiou, Katerina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532963/ https://www.ncbi.nlm.nih.gov/pubmed/36213643 http://dx.doi.org/10.3389/fmed.2022.1020859 |
Ejemplares similares
-
Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study
por: Md Yusof, Md Yuzaiful, et al.
Publicado: (2023) -
Editorial: Psychological impact and quality of life in rheumatic and musculoskeletal diseases
por: Talarico, Rosaria, et al.
Publicado: (2023) -
Rheumatic disease and artistic creativity
por: Chatzidionysiou, Katerina
Publicado: (2019) -
Biologic Sequencing in Systemic Lupus Erythematosus: After Secondary Non-response to Rituximab, Switching to Humanised Anti-CD20 Agent Is More Effective Than Belimumab
por: Hassan, Sabih Ul, et al.
Publicado: (2020) -
Editorial: Innovation in Rheumatic Diseases
por: Jacinto, Maria João, et al.
Publicado: (2022)